Chiral-Selective Antigen-Presentation by Supramolecular Chiral Polymer Micelles.
Hejin JiangRui LiuLu WangXinyue WangMengmeng ZhangSisi LinZhenping CaoFeng WuYingbin LiuJinyao LiuPublished in: Advanced materials (Deerfield Beach, Fla.) (2022)
Chirality is ubiquitous in biological systems, which is closely related to biological functions, life process, and even pathogenesis of diseases. However, the interface between the chirality of synthetic materials and organisms, particularly the immune system, remains poorly understood. Here, supramolecular chiral polymer micelles (SCPMs) are prepared by complexing antigenic proteins with chiral amino acid modified polyethyleneimine. The introduction of chirality not only reduces the toxicity of cationic polymer, but also benefits cell uptake and antigen presentation. Especially, D-chirality presents the lowest cytotoxicity, while promotes the highest expression level of costimulatory molecules on dendritic cells compared to L-chirality and achirality. The superiority of D-chirality to stimulate dendritic cell maturation is supported by immunization with D-SCPMs, which achieves significant antigen-specific proliferation of T cells in the spleen, lymph nodes and tumor of mice. Chirality-mediated antigen processing and presentation is demonstrated by D-SCPMs self-assembled from chiral alkaline histidine or neutral phenylalanine modified polyethyleneimine and tumor associated ovalbumin or severe acute respiratory syndrome coronavirus 2 spike 1 antigenic protein. Immunoactivation enabled by D-chirality opens a window to prepare potent nanotherapeutics for disease prevention and treatment. This article is protected by copyright. All rights reserved.
Keyphrases
- dendritic cells
- capillary electrophoresis
- ionic liquid
- amino acid
- respiratory syndrome coronavirus
- lymph node
- drug delivery
- sars cov
- signaling pathway
- immune response
- regulatory t cells
- case report
- oxidative stress
- poor prognosis
- cancer therapy
- single cell
- stem cells
- type diabetes
- early stage
- cell therapy
- neoadjuvant chemotherapy
- mass spectrometry
- adipose tissue
- insulin resistance
- combination therapy
- energy transfer
- anaerobic digestion